Oragenics Free Cash Flow (FCF) History (OGEN)
Oragenics reported −$15.4M in free cash flow for fiscal 2022, a decrease of $1.8M from the previous fiscal year, with a free cash flow margin of −11675.70%.
View full Oragenics company overviewOragenics free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2022 | 2022-12-31 | −$15.4M | −$1.8M | — | −11675.70% |
| 2021 | 2021-12-31 | −$13.5M | −$476,031 | — | −15535.76% |
| 2019 | 2019-12-31 | −$13.0M | −$3.8M | — | — |
| 2018 | 2018-12-31 | −$9.2M | −$2.1M | — | — |
| 2016 | 2016-12-31 | −$7.1M | −$1.8M | — | — |
| 2015 | 2015-12-31 | −$5.3M | $377,802 | — | — |
| 2014 | 2014-12-31 | −$5.7M | $1.1M | — | −603.22% |
| 2013 | 2013-12-31 | −$6.8M | −$1.6M | — | −657.15% |
| 2012 | 2012-12-31 | −$5.2M | $1.3M | — | −392.18% |
| 2010 | 2010-12-31 | −$6.5M | — | — | −499.39% |
Oragenics quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2022 | 2022-12-31 | −$2.4M | $941,432 | — | — |
| Q3 2022 | 2022-09-30 | −$3.8M | −$2.2M | — | −4431.21% |
| Q2 2022 | 2022-06-30 | −$3.4M | −$2.0M | — | −11130.94% |
| Q1 2022 | 2022-03-31 | −$5.7M | −$4.8M | — | −37950.00% |
| Q3 2019 | 2019-09-30 | −$3.4M | −$2.0M | — | — |
| Q4 2015 | 2015-12-31 | −$1.6M | −$346,442 | — | — |
| Q3 2015 | 2015-09-30 | −$1.3M | −$249,197 | — | — |
| Q2 2015 | 2015-06-30 | −$965,342 | $730,912 | — | −398.84% |
| Q1 2015 | 2015-03-31 | −$1.4M | $242,529 | — | −374.03% |
| Q4 2014 | 2014-12-31 | −$1.3M | $704,063 | — | −576.53% |
| Q3 2014 | 2014-09-30 | −$1.1M | $469,295 | — | −546.81% |
| Q2 2014 | 2014-06-30 | −$1.7M | — | — | −558.43% |
| Q1 2014 | 2014-03-31 | −$1.6M | — | — | −746.83% |
| Q3 2013 | 2013-09-30 | −$2.0M | — | — | −779.61% |
| Q3 2010 | 2010-09-30 | −$1.6M | — | — | −430.21% |
Oragenics free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$5.3M to −$15.4M, a net decrease of $10.1M. Oragenics's latest reported quarter, Q4 2022, generated −$2.4M in free cash flow, an increase of $941,432 year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Oragenics filings at SEC.gov ↗